Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics

Annals of Allergy, Asthma and Immunology

Volumn 98, Issue 1, 2007, Pages 51-56

  Hung, Shuo Hsun ^a   Lin, Yu Tsan ^a   Chu, Chia Yu ^a   Lee, Chien Chang ^a   Liang, Tien Chi ^a   Yang, Yao Hsu ^a   Wang, Li Chieh ^a   Chiang, Bor Luen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; CETIRIZINE; FLUTICASONE PROPIONATE; FUSIDATE SODIUM; FUSIDIC ACID; GLUCOCORTICOID; TACROLIMUS;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; BURNING SENSATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG WITHDRAWAL; ERADICATION THERAPY; FEMALE; HUMAN; INFANT; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN ALLERGY; SLEEP DISORDER; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 33846252330     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60859-9     Document Type: Article

References (33)

1. Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361: 151-160.
2. Lübbe J. Secondary infections in patients with atopic dermatitis. Am J Clin Dermatol. 2003;4:641-654.
3. Lin YT, Shau WY, Wang LF, et al. Comparison of serum specific IgE antibodies to staphylococcal enterotoxins between atopic children with and without atopic dermatitis. Allergy. 2000;55:641-646.
4. Lin YT, Wang CT, Chiang BL. Role of bacterial pathogens in atopic dermatitis. Clin Rev Allergy Immunol. In press.
5. + T cells from atopic dermatitis patients and healthy subjects: the inhibitory effect of IL-4 on SsAg-induced apoptosis. J Immunol. 2003;171:1102-1108.
6. Hauk PJ, Hamid QA, Chrousos GP, Leung DY. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol. 2000;105:782-787.
7. Hauk PJ, Leung DY. Tacrolimus (FK506): new treatment approach in superantigen-associated diseases like atopic dermatitis? J Allergy Clin Immunol. 2001;107:391-392.
8. Wachs GN, Maibach HI. Co-operative double-blind trial of an antibiotic/corticoid combination in impetiginized atopic dermatitis. Br J Dermatol. 1976;95:323-328.
9. Leyden JJ, Kligman AM. The case for steroid-antibiotic combinations. Br J Dermatol. 1977;96:179-187.
10. Hjorth N, Schmidt H, Thomsen K. Fusidic acid plus betamethasone in infected or potentially infected eczema. Pharmatherapeutica. 1985;4:126-131.
11. Nilsson E, Henning C, Hjörleifsson ML. Density of the microflora in hand eczema before and after topical treatment with a potent corticosteroid. J Am Acad Dermatol. 1986;15:192-197.
12. Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol. 1992;27:29-34.
13. Stalder JF, Fleury M, Sourisse M, Rostin M, Pheline F, Litoux P. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol. 1994;131:536-540.
14. Guzik TJ, Bzowska M, Kasprowicz A, et al. Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. Clin Exp Allergy. 2005;35:448-455.
15. Pournaras CC, Lübbe Jann, Saurat JH. Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (Fk506). J Invest Dermatol. 2001;116:480-481.
16. Remitz A, Kyllönen H, Granlund H, Reïtamo S. Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J Allergy Clin Immunol. 2001;107:196-197.
17. Williams RE. The antibacterial-corticosteroid combination: what is its role in atopic dermatitis? Am J Clin Dermatol. 2000;1:211-215.
18. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol Venereol (Stockh). 1980;92(suppl):44-47.
19. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl. 1989;144:13-14.
20. Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;915:10-19.
21. Williamson P, Kligman AM. A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol. 1965;45: 498-503.
22. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol. 1974;90: 525-530.
23. Gilani SJ, Gonzalez M, Hussain I, Finlay AY, Patel GK. Staphylococcus aureus re-colonization in atopic dermatitis: beyond the skin. Clin Exp Dermatol. 2004;30:10-13.
24. Reitamo S, Rustin M, Ruzicka T, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol. 2002;109:547-555.
25. Cho SH, Strickland I, Tomkinson A, Fehringer AP, Gelfand EW, Leung DY. Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model. J Invest Dermatol. 2001;116:658-663.
26. Lever R, Hadley K, Downey D, Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol. 1988;119:189-198.
27. Ewing CI, Ashcroft C, Gibbs AC, Jones GA, Connor PJ, David TJ. Flucloxacillin in the treatment of atopic dermatitis. Br J Dermatol. 1998;138:1022-1029.
28. Breuer K, Häussler S, Kapp A, Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol. 2002;147:55-61.
29. Boguniewicz M, Sampson H, Leung SB, Harbeck R, Leung DY. Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis. J Allergy Clin Immunol. 2001;108:651-652.
30. Patel GK, Wyatt H, Kubiak EM, Clark SM, Mills CM. Staphylococcus aureus colonization of children with atopic eczema and their parents. Acta Derm Venereol. 2001;81:366-367.
31. David TJ, Cambridge GC. Bacterial infection and atopic eczema. Arch Dis Child. 1986;61:20-23.
32. Shah M, Mohanraj M. High levels of fusidic acid-resistant Staphylococcus aureus in dermatology patients. Br J Dermatol. 2003;148:1018-1020.
33. Peeters KA, Mascini EM, Sanders CJ. Resistance of Staphylococcus aureus to fusidic acid. Int J Dermatol. 2004;43:235-236.